Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Pharmaust Limited ( (AU:NUZ) ) has shared an update.
Neurizon Therapeutics Limited has called a virtual-only General Meeting of shareholders for 20 February 2026 at 2:00pm AEDT, to be held via an online meeting platform, with all meeting materials, including the Notice of Meeting and explanatory statement, provided electronically through the company’s website, share registry portal, and ASX announcements page. The move underscores Neurizon’s shift away from physical mailouts toward digital communication, streamlining shareholder engagement and voting processes while encouraging investors to update their communication preferences, submit proxies ahead of the meeting, and utilise online channels for access and participation, which may enhance accessibility and reduce administrative costs for the company and its stakeholders.
The most recent analyst rating on (AU:NUZ) stock is a Buy with a A$0.56 price target. To see the full list of analyst forecasts on Pharmaust Limited stock, see the AU:NUZ Stock Forecast page.
More about Pharmaust Limited
Neurizon Therapeutics Limited is an Australian biotechnology company listed on the ASX under the code NUZ, focused on therapeutic development in the life sciences sector. The company engages with a diverse base of retail and institutional shareholders, who receive corporate communications and governance materials primarily through electronic channels, reflecting Neurizon’s adoption of digital-first investor relations practices.
Average Trading Volume: 527,190
Technical Sentiment Signal: Sell
Current Market Cap: A$68.01M
Find detailed analytics on NUZ stock on TipRanks’ Stock Analysis page.